04/15/2024
4:01 PM | Reviva Pharmaceuticals (Filer)
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/15/2024
7:20 AM | Reviva Pharmaceuticals (Filer)
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/15/2024
7:22 AM | Reviva Pharmaceuticals (Filer)
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
04/15/2024
6:45 AM | Reviva Pharmaceuticals (Filer)
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2024
7:00 AM | Reviva Pharmaceuticals (Filer)
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer)
| Form NT 10-K | |
02/16/2024
3:32 PM | Bhat Laxminarayan (Filed by)
Reviva Pharmaceuticals (Subject)
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Subject)
| Form SC 13D/A | |
02/02/2024
3:38 PM | Reviva Pharmaceuticals (Filer)
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/22/2023
5:28 PM | Reviva Pharmaceuticals (Issuer)
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Issuer)
SAXENA PARAG (Reporting)
VEDANTA ASSOCIATES, L.P. (Reporting)
VEDANTA PARTNERS, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2023
3:12 PM | Reviva Pharmaceuticals (Filer)
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/30/2023
7:20 AM | Reviva Pharmaceuticals (Filer)
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2023
4:19 PM | Reviva Pharmaceuticals (Filer)
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer)
| Form ARS | |
10/04/2023
4:02 PM | Reviva Pharmaceuticals (Filer)
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2023
4:03 PM | Reviva Pharmaceuticals (Filer)
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer)
| Form DEF 14A | |
08/17/2023
5:30 AM | Reviva Pharmaceuticals (Filer)
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/24/2023
3:16 PM | Reviva Pharmaceuticals (Filer)
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/23/2023
5:30 AM | Reviva Pharmaceuticals (Filer)
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/05/2023
3:30 PM | Bhat Laxminarayan (Filed by)
Reviva Pharmaceuticals (Subject)
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Subject)
| Form SC 13D/A | |
04/27/2023
3:30 PM | Narayan Prabhu (Reporting)
Reviva Pharmaceuticals (Issuer)
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/27/2023
3:30 PM | Reviva Pharmaceuticals (Filer)
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/27/2023
3:31 PM | Bhat Laxminarayan (Reporting)
Reviva Pharmaceuticals (Issuer)
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
